Table 2.
Blood routine tests after in vivo administration of synthesized nanoprobes
| Baseline | Month one | Month three | |
|---|---|---|---|
| WBC (109/L) | 6.7±1.7 | 5.5±1.2 | 6.5±1.4 |
| HGB (g/dL) | 14.3±1.9 | 15.4±2.3 | 14.9±2.1 |
| PLT (109/L) | 49±18 | 39±15 | 42±16 |
| GRANS (109/L) | 2.5±1.1 | 2.8±1.4 | 2.6±1.3 |
| % GRANS | 37±11 | 50±16 | 43±13 |
| HCT (%) | 53.8±1.3 | 55.6±1.8 | 55.1±1.4 |
| MCHC (g/dL) | 28.9±1.7 | 25.8±2.6 | 26.8±2.1 |
| L/M (109/L) | 4.2±2.1 |
|
3.9±1.8 |
| % L/M | 63±9 | 44±11 | 49±9 |
| RETICS (%) | 0.7±0.3 | 0.5±0.2 | 0.6±0.3 |
Note: Data were expressed as mean±SD, n=6.
Abbreviations: WBC, white blood cells; HGB, hemoglobin; PLT, platelets; GRANS, granulocytes; HCT, hematocrit; MCHC, mean corpuscular hemoglobin concentration; L/M, lymphocytes; RETICS, reticulocytes.